Crospovidone is safe for the vast majority of people. It’s a pharmaceutical inactive ingredient, not a drug itself, and your body doesn’t absorb it. The World Health Organization has set an acceptable daily intake of up to 50 mg per kilogram of body weight, and long-term animal studies at very high doses have found no significant toxic effects. That said, there are a few edge cases worth knowing about.
What Crospovidone Actually Does
Crospovidone is a synthetic, water-insoluble polymer made from cross-linked polyvinylpyrrolidone. Its job in a pill is simple: it helps the tablet break apart quickly once it hits your stomach. Pharmaceutical manufacturers call it a “superdisintegrant” because even a small amount causes a tablet to swell and fragment on contact with moisture, releasing the active drug faster. It has no therapeutic effect on its own. You’ll find it in tablets, capsules, and dietary supplements as a listed inactive ingredient.
Because crospovidone is completely insoluble, it passes through the digestive tract without being absorbed into the bloodstream. It essentially travels in, does its job of breaking up the tablet, and travels out. In some countries, including France, this same property has been used intentionally: crospovidone is given as a treatment for certain gastrointestinal conditions, where it coats the intestinal lining and adsorbs bacterial toxins.
What Long-Term Studies Show
The most relevant safety data comes from chronic toxicity studies in rats and dogs. Rats were fed copovidone (a closely related polymer) at doses up to 2,800 mg per kilogram of body weight daily for two full years. Dogs received up to 2,500 mg/kg daily for a year. In both species, researchers found no treatment-related blood changes, no organ damage, and no cancerous growths. The only observable effect in rats was darker stool from excreting large amounts of the substance, which wasn’t considered harmful.
In the dogs, some immune cells in lymph nodes near the intestines showed signs of clearing the ingested material, a normal housekeeping response rather than a toxic one. The conclusion: the highest doses tested produced no adverse effects. For context, those doses are hundreds of times higher than what any person would encounter from taking medications.
How Much Is Considered Safe
The Joint FAO/WHO Expert Committee on Food Additives (JECFA) established an acceptable daily intake of 0 to 50 mg per kilogram of body weight for polyvinylpyrrolidone, the parent compound family. For a 150-pound person, that works out to roughly 3,400 mg per day. A typical tablet contains somewhere between 10 and 50 mg of crospovidone. Even if you take multiple medications daily, you’d be well below that threshold.
Pharmaceutical-grade crospovidone also has strict purity requirements. The U.S. Pharmacopeia limits residual vinylpyrrolidinone (the raw monomer used to make the polymer) to no more than 10 parts per million, and heavy metals to no more than 10 ppm. These limits ensure that the trace impurities present in the manufacturing process stay at negligible levels.
Allergic Reactions Are Rare but Possible
True allergic reactions to crospovidone are uncommon, but they do exist. Povidone, the soluble form of the same polymer family, has triggered anaphylaxis in rare cases after exposure through oral tablets, eye drops, facial creams, and injected corticosteroids. If you have a confirmed allergy to povidone, you may also react to crospovidone. Allergists consider the two cross-reactive, meaning the immune system can mistake one for the other. In Europe, crospovidone used in food is labeled as E1202, which can help you identify it on ingredient lists.
One important clarification: povidone-iodine (the brown antiseptic) contains iodine bonded to povidone, but a povidone allergy is not the same as an iodine allergy or a reaction to radiocontrast dyes used in medical imaging. These are separate immune pathways. If you’ve reacted to povidone-iodine and want to know which component caused it, skin prick testing can help distinguish between the two.
Risks From Misuse, Not From Swallowing
The most serious documented harms from crospovidone have nothing to do with taking pills as intended. When people crush and inject tablets containing crospovidone, the insoluble particles enter the bloodstream and lodge in small blood vessels. This has been linked to a condition called pulmonary angiothrombosis, where the particles cause blockages and foreign body reactions in the lungs. More recently, crospovidone deposits have been identified in the skin of people who injected crushed buprenorphine tablets subcutaneously.
These cases are specific to injection drug use and represent a fundamentally different exposure route than swallowing a tablet. When taken orally as designed, crospovidone stays in the gut and never reaches the bloodstream. The foreign body reactions seen in injection cases reinforce why the substance is safe in the digestive tract: it’s inert and insoluble, which is harmless when passing through the intestines but problematic when forced into blood vessels where it doesn’t belong.